Ralph Abraham

501 total citations
17 papers, 395 citations indexed

About

Ralph Abraham is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Immunology. According to data from OpenAlex, Ralph Abraham has authored 17 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Radiology, Nuclear Medicine and Imaging, 6 papers in Molecular Biology and 4 papers in Immunology. Recurrent topics in Ralph Abraham's work include Monoclonal and Polyclonal Antibodies Research (6 papers), Molecular Junctions and Nanostructures (3 papers) and T-cell and B-cell Immunology (3 papers). Ralph Abraham is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), Molecular Junctions and Nanostructures (3 papers) and T-cell and B-cell Immunology (3 papers). Ralph Abraham collaborates with scholars based in United States, Germany and Sweden. Ralph Abraham's co-authors include Linda Xu, Suzanne J. Suchard, Steven G. Nadler, Patricia M. Davis, Karl Erik Hellström, Ingegerd Hellström, Detlef Gabel, Peter D. Senter, Michael J. Darsley and Qi Guo and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Ralph Abraham

17 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ralph Abraham United States 8 141 129 107 102 91 17 395
Shuaiyi Liang China 6 159 1.1× 127 1.0× 69 0.6× 76 0.7× 128 1.4× 11 359
Erica Houthuys Belgium 8 154 1.1× 48 0.4× 30 0.3× 67 0.7× 108 1.2× 14 291
Rudo Simeon United States 9 154 1.1× 98 0.8× 20 0.2× 87 0.9× 60 0.7× 12 354
Karen Williamson United States 9 186 1.3× 30 0.2× 94 0.9× 124 1.2× 180 2.0× 10 544
John Bui United States 10 184 1.3× 40 0.3× 251 2.3× 174 1.7× 173 1.9× 12 567
Jana Václavíková United States 6 121 0.9× 113 0.9× 29 0.3× 41 0.4× 275 3.0× 8 578
Paul R. Wratil Germany 11 221 1.6× 60 0.5× 20 0.2× 79 0.8× 49 0.5× 23 369
Wendy Bernhard Canada 13 138 1.0× 156 1.2× 112 1.0× 81 0.8× 47 0.5× 26 418
Renee C. Duncan Australia 11 88 0.6× 40 0.3× 88 0.8× 57 0.6× 336 3.7× 17 514
Mirja Harms Germany 11 172 1.2× 48 0.4× 20 0.2× 58 0.6× 65 0.7× 25 349

Countries citing papers authored by Ralph Abraham

Since Specialization
Citations

This map shows the geographic impact of Ralph Abraham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph Abraham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph Abraham more than expected).

Fields of papers citing papers by Ralph Abraham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph Abraham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph Abraham. The network helps show where Ralph Abraham may publish in the future.

Co-authorship network of co-authors of Ralph Abraham

This figure shows the co-authorship network connecting the top 25 collaborators of Ralph Abraham. A scholar is included among the top collaborators of Ralph Abraham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralph Abraham. Ralph Abraham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Abraham, Ralph, et al.. (2021). P57.04 Predicting Treatment Response to 1st- line Pembrolizumab in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients with High PDL1 Expression. Journal of Thoracic Oncology. 16(10). S1138–S1138. 1 indexed citations
2.
Devitt, Michael, Ralph Abraham, Bethany J. Horton, et al.. (2018). Risk of CNS adverse events (CNS-AEs) for patients with non-small cell lung cancer (NSCLC) and melanoma brain metastases (BM) treated with CNS radiation (CNS-RT) and immune checkpoint inhibitors (CPIs).. Journal of Clinical Oncology. 36(15_suppl). 2010–2010. 1 indexed citations
3.
Abraham, Ralph, et al.. (2018). Bleeding Risk of Low-Molecular Weight Heparin Vs Direct Oral Anticoagulant in Patients with Intracranial Tumors. Blood. 132(Supplement 1). 2524–2524. 3 indexed citations
4.
Ma, Jennifer, et al.. (2015). The Impact of Biologically Effective Dose on Keloid Recurrence After Postoperative Electron Beam Radiation Therapy in African American Patients. International Journal of Radiation Oncology*Biology*Physics. 93(3). E462–E462. 1 indexed citations
5.
Carmo, Jussara M. do, Alexandre A. da Silva, Ralph Abraham, et al.. (2014). Shp2 signaling in POMC neurons is important for leptin's actions on blood pressure, energy balance, and glucose regulation. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 307(12). R1438–R1447. 30 indexed citations
6.
Giri, Shankar, et al.. (2014). Comparison of Cisplatin Versus Cetuximab With Intensity Modulated Radiation Therapy in Locally Advanced Squamous Cell Carcinomas of Head and Neck: Toxicity, Patterns of Failure, and Survival Analysis. International Journal of Radiation Oncology*Biology*Physics. 90(1). S565–S565. 2 indexed citations
7.
Giri, Shankar, et al.. (2014). Outcome Analysis of Extracapsular Extension in Cervical Lymph Nodes for Locally Advanced Squamous Cell Carcinomas of Head and Neck. International Journal of Radiation Oncology*Biology*Physics. 90(1). S552–S553. 1 indexed citations
8.
Kaur, Parminder, Qiang Fu, Alexander Fuhrmann, et al.. (2011). Antibody-Unfolding and Metastable-State Binding in Force Spectroscopy and Recognition Imaging. Biophysical Journal. 100(1). 243–250. 14 indexed citations
9.
Chen, Shen-Jue, William R. Foster, Maria Jure–Kunkel, et al.. (2008). Cloning, expression and characterization of monkey (Macaca fascicularis) CD137. Veterinary Immunology and Immunopathology. 126(3-4). 377–381. 2 indexed citations
10.
Davis, Patricia M., Ralph Abraham, Linda Xu, Steven G. Nadler, & Suzanne J. Suchard. (2007). Abatacept binds to the Fc receptor CD64 but does not mediate complement-dependent cytotoxicity or antibody-dependent cellular cytotoxicity.. PubMed. 34(11). 2204–10. 80 indexed citations
11.
Jure‐Kunkel, Maria, Sandra A. Calarota, Ralph Abraham, et al.. (2006). Adoptively transferred tumor-specific T cells expanded ex vivo using HSV amplicons encoding 4-1BBL show increased anti-tumor activity in vivo. Cancer Research. 66. 1117–1117. 1 indexed citations
12.
Guo, Qi, Hsu‐Tso Ho, Ira B. Dicker, et al.. (2003). Biochemical and Genetic Characterizations of a Novel Human Immunodeficiency Virus Type 1 Inhibitor That Blocks gp120-CD4 Interactions. Journal of Virology. 77(19). 10528–10536. 130 indexed citations
13.
14.
Abraham, Ralph, et al.. (1996). Determination of binding constants of diabodies directed against prostate-specific antigen using electrochemiluminescence-based immunoassays. Journal of Molecular Recognition. 9(5-6). 456–461. 5 indexed citations
15.
Abraham, Ralph, et al.. (1995). Screening and kinetic analysis of recombinant anti-CEA antibody fragments. Journal of Immunological Methods. 183(1). 119–125. 29 indexed citations
16.
17.
Abraham, Ralph, et al.. (1991). The influence of periodate oxidation on monoclonal antibody avidity and immunoreactivity. Journal of Immunological Methods. 144(1). 77–86. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shuaiyi Liang Breakdown of academic impact, for papers by Erica Houthuys Breakdown of academic impact, for papers by Rudo Simeon Breakdown of academic impact, for papers by Karen Williamson Breakdown of academic impact, for papers by John Bui Breakdown of academic impact, for papers by Jana Václavíková Breakdown of academic impact, for papers by Paul R. Wratil Breakdown of academic impact, for papers by Wendy Bernhard Breakdown of academic impact, for papers by Renee C. Duncan Breakdown of academic impact, for papers by Mirja Harms
Rankless by CCL
2026